Comparison of maintenance with decitabine or chemotherapy in a real-world cohort of patients with acute myeloid leukemia.
Saved in:
| Title: | Comparison of maintenance with decitabine or chemotherapy in a real-world cohort of patients with acute myeloid leukemia. |
|---|---|
| Authors: | Wei ZF; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China., Yan JQ; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China., Tan YH; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China., Lin H; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China., Liu QJ; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China., Liu XL; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China., Su L; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China., Gao SJ; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Feb 13; Vol. 17, pp. 1753030. Date of Electronic Publication: 2026 Feb 13 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41769689 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparison of maintenance with decitabine or chemotherapy in a real-world cohort of patients with acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wei+ZF%22">Wei ZF</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Yan+JQ%22">Yan JQ</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Tan+YH%22">Tan YH</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Lin+H%22">Lin H</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Liu+QJ%22">Liu QJ</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Liu+XL%22">Liu XL</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Su+L%22">Su L</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Gao+SJ%22">Gao SJ</searchLink>; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Key Laboratory of Hematology Precision Medicine of Jilin Province, The First Hospital of Jilin University, Changchun, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 Feb 13; Vol. 17, pp. 1753030. <i>Date of Electronic Publication: </i>2026 Feb 13 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41769689 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2026.1753030 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1753030 Titles: – TitleFull: Comparison of maintenance with decitabine or chemotherapy in a real-world cohort of patients with acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wei ZF – PersonEntity: Name: NameFull: Yan JQ – PersonEntity: Name: NameFull: Tan YH – PersonEntity: Name: NameFull: Lin H – PersonEntity: Name: NameFull: Liu QJ – PersonEntity: Name: NameFull: Liu XL – PersonEntity: Name: NameFull: Su L – PersonEntity: Name: NameFull: Gao SJ IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 02 Text: 2026 Feb 13 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 17 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |